Statins alter oxidant-antioxidant status and lower exercise-induced oxidative stress

International Journal of Clinical Pharmacology and Therapeutics

Volumn 45, Issue 4, 2007, Pages 244-252

  Delliaux, S ^a,b   Steinberg, J G ^a,b   Bechis, G ^b   Paganelli, F ^b   Oliver, C ^c   Lesavre, N ^c   Jammes, Y ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL NORD   (France)

^c Centre d'Investigation Clinique   (France)

Author keywords

Exercise; Lipids; Oxidative stress; Skeletal muscle; Statin

Indexed keywords

ASCORBIC ACID; ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DYSLIPIDEMIA; EXHAUSTION; FATIGUE; FEMALE; HUMAN; ISOMETRIC EXERCISE; LIFESTYLE; LONGITUDINAL STUDY; MALE; MUSCLE FUNCTION; MYALGIA; OXIDATIVE STRESS; REST; SIDE EFFECT; SLOW MUSCLE FIBER;

EID: 34247387904     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP45244     Document Type: Article

References (52)

1. Agacdiken A, Basyigit I, Ozden M, Yildiz F, Ural D, Maral H, Boyaci H, Ilgazli A, Komsuoglu B. The effects of antioxidants on exercise-induced lipid peroxidation in patients with COPD. Respirology. 2004; 9: 38-42.
2. Alessio HM. Exercise-induced oxidative stress. Med Sci Sports Exerc. 1993; 25: 218-224.
3. Badier M, Guillot C, Lagier-Tessonnier F, Burnet H, Jammes Y. EMG power spectrum of respiratory and skeletal muscles during static contraction in healthy man. Muscle Nerve. 1993; 16: 601-609.
4. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J. 1973; 134: 707-716.
5. Chakraborti T, Ghosh SK, Michael JR, Batabyal SK, Chakraborti S. Targets of oxidative stress in cardiovascular system. Mol Cell Biochem. 1998; 187: 1-10.
6. Chance B, William GR. The respiratory chain and oxidative phosphorylation. Adv Enzymol Relat Subj Biochem. 1956; 17: 65-134.
7. Delliaux S, Steinberg JG, Lesavre N, Paganelli F, Oliver C, Jammes Y. Mechanical and electrophysiological muscle consequences of long-term atorvastatin treatment. Int J Clin Pharmacol Ther. 2006; 44: 251-261.
8. Dousset E, Steinberg JG, Faucher M, Jammes Y., Acute hypoxemia does not increase the oxidative stress in resting and contracting muscle in humans. Free Radic Res. 2002; 36: 701-704.
9. Durrington P. Dyslipidaemia. Lancet. 2003; 362: 717-731.
10. Evans M, Rees A. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same? Drug Saf. 2002; 25: 649-663.
11. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA. 1989; 86: 6377-6381.
12. Fulle S, Mecocci P, Farto G. Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. Free Radic Biol Med. 2000; 29: 1252-1259.
13. Glascott PA Jr. Tsyganskaya M, Gilfor E, Zern MA, Farber JL. The antioxidant function of the physiological content of vitamin C. Mol Pharmacol. 1996; 50: 994-999.
14. Haendeler J, Hoffmann J, Zeiher AM, Dimmeler S. Anti-oxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Circulation. 2004; 110: 856-861.
15. Hochachka PW. Supplying muscle machines with energy, oxidative metabolism in muscles as molecular and metabolic machines. Boca Raton, FL, USA: CRC; 1994a. p. 86.
16. Hochachka PW. Isoform definition of muscle machines in muscles as molecular and metabolic machines. Boca Raton, FL, USA: CRC; 1994b. p. 119-150.
17. Jammes Y, Steinberg JG, Bregeon F, Delliaux S. The oxidative stress in response to routine incremental cycling exercise in healthy sedentary subjects. Respir Physiol Neurobiol. 2004; 144: 81-90.
18. Jammes Y, Steinberg JG, Mambrini O, Bregeon F, Delliaux S. Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J Intern Med. 2005; 257: 299-310.
19. Johnson MA, Polgard J, Weightman D, Appleton D. Data on the distribution of fibre types in 36 human muscles. An autopsy study. J Neurol Sci. 1973; 18: 111-129.
20. Joulia F, Steinberg JG, Faucher M, Jamin T, Ulmer C, Kipson N, Jammes Y. Breath-hold training of humans reduces oxidative stress and blood acidosis after static and dynamic apnea. Respir Physiol Neurobiol. 2003; 137: 19-27.
21. Jula A, Marniemi J, Huupponen R, Virtanen A, Rastas M, Ronnemaa T. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypemholesterolemic men: a randomized controlled trial. JAMA. 2002; 287: 598-605.
22. Kowalski J, Blaszczyk J, Olejniczak J, Kowalski M, Blaszczyk-Suszynska J, Petecka E, Kedziora J, Gburek J. Effect of fluvastatin and fenofibrate on reactive oxygen species generation and lipid peroxidation in patients with dyslipidemia. Pol Merkuriusz Lek. 2003; 14: 279-284.
23. Lea AP, McTavish D. Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs. 1997; 53: 828-847.
24. Lefer AM, Scalia R, Lefer DJ. Vascular effects of HMG CoA-reductase inhibitors (statins)unrelated to cholesterol lowering: new concepts for cardiovascular disease. Cardiovasc Res. 2001; 49: 281-287.
25. Lennernas H, Fager G. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinet. 1997; 32: 403-425.
26. Maeda K, Yasunari K, Saro EF, Inoue M. Enhanced oxidative stress in neutrophils from hyperlipidemic guinea pig. Atherosclerosis. 2005; 181: 87-92.
27. Mahfouz MM, Kummerow FA. Atorvastatin reduces the plasma lipids and oxidative stress but did not reverse the inhibition of prostacyclin generation by aortas in streptozotocin diabetic rats. Prostaglandins Other Lipid Mediat. 2005; 76: 59-73.
28. Maickel RP. A rapid procedure for the determination of adrenal ascorbic acid. Application of the Sullivan and Clarke method to tissues. Anal Biochem. 1960; 1: 498-501.
29. Meagher EA, FitzGerald GA. Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med. 2000; 28: 1745-1750.
30. Morillas-Ruiz J, Zafrilla P, Almar M, Cuevas MJ, Lopez FJ, Abellan P, Villegas JA, Gonzalez-Gallego J. The effects of an antioxidant-supplemented beverage on exercise-induced oxidative stress: results from a placebo-controlled double-blind study in cyclists. Eur J Appl Physiol. 2005; 95: 543-549.
31. Murphy ME, Kehrer JP. Oxidative stress and muscular dystrophy. Chem Biol Interact. 1989; 69: 101-173.
32. Olson RE, Rudney H. Biosynthesis of ubiquinone. Vitam Horm. 1983; 40: 1-43.
33. 2 sensing in oxygen sensing: responses and adaptation to hypoxia. New York, USA: Marcel Dekker; 2003. p. 523-532.
34. Richards RS, Roberts TK, McGregor NR, Dunstan RH, Butt HL. Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep. 2000; 5: 35-41.
35. Rokitzki L, Logermann E, Sagredos A, Murphy M, Xetzel-Roth W, Keul J. Lipid peroxidation and antioxidative vitamins under extreme endurance stress. Acta Physiol Scand. 1994; 151: 149-158.
36. Rudney H, Sexton RC. Regulation of cholesterol bio-synthesis. Annu Rev Nutr. 1986; 6: 245-272.
37. Schulz HU, Schurer M, Krupp S, Dammann HG, Timm J, Gessner U. Effects of acetylsalicylic acid on ascorbic acid concentrations in plasma, gastric mucosa, gastric juice and urine - a double-blind study in healthy subjects. Int J Clin Pharmacol Ther. 2004; 42: 481-487.
38. Sen CK. Oxidants and antioxidants in exercise. J Appl Physiol. 1995; 79: 675-686.
39. Senturk UK, Gunduz F, Kuru O, Kocer G, Ozkaya YG, Yesilkaya A, Bor-Kucukatay M, Uyuklu M, Yalzin O, Baskurt OK. Exercise-induced oxidative stress leads hemolysis in sedentary but not trained humans. J Appl Physiol. 2005; 99:1434-1441.
40. Shishehbor MH, Aviles RJ, Brennan ML, Fu X, Goormastic M, Pearce GL, Gokce N, Keaney JF Jr, Penn MS, Sprecher DL, Vita JA, Hazen SL. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA. 2003a; 289: 1675-1680.
41. Shishehbor MH, Brennan ML, Aviles RJ, Fu X, Penn MS, Sprecher DL, Hazen SL. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation. 2003b; 108: 426-431.
42. Steinberg JG, Gainnier M, Michel F, Faucher M, Arnaud C, Jammes Y. The post-exercise oxidative stress is depressed by acetylsalicylic acid. Respir Physiol Neurobiol. 2002; 130: 189-199.
43. Steinberg JG Delliaux S, Jammes Y. Reliability of different blood indices to explore the oxidative stress in response to maximal cycling and static exercises. Clin Physiol Funct Imaging. 2006; 26: 106-112.
44. Stroes E. Statins and LDL-cholesterol lowering: an overview. Curr Med Res Opin. 2005; 21 (Suppl 6): 9-16.
45. Sugiyama M, Ohashi M, Takase H, Sato K, Ueda R, Dohi Y. Effects of atorvastatin on inflammation and oxidative stress. Heart Vessels. 2005; 20: 133-136.
46. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003; 552: 335-344.
47. Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978; 86: 271-278.
48. Vasankari T, Ahotupa M, Viikari J, Nuotio I, Strandberg T, Vanhanen H, Gylling H, Miettinen T, Tikkanen MJ. Effect of 12-month statin therapy on antioxidant potential of LDL and serum antioxidant vitamin concentrations. Ann Med. 2004; 36: 618-622.
49. Vaughan CJ, Murphy MB, Buckley BM. Statins do more than just lower cholesterol. Lancet. 1996; 348: 1079-1082.
50. Vecchiet J, Cipollone F, Falasca K. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett. 2003; 335: 151-154.
51. Wassmann S, Lauf U, Baumer AT, Muller K, Ahlbory K, Linz W, Itter G, Rosen R, Bohm M, Nickenig G. HMG-coA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension. 2001; 37: 1450-1457.
52. Wassmann S, Lauf U, Muller K, Konkol C, Ahlbory K, Baumer AT, Linz W, Bohm M, Nickenig G. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2002; 22: 300-305.